Literature DB >> 21659733

Quantitating glomerular endothelial fenestration: an unbiased stereological approach.

Behzad Najafian1, Michael Mauer.   

Abstract

BACKGROUND/AIMS: Glomerular endothelial cells are fenestrated, allowing for especially high transcellular hydraulic conductivity. Current knowledge about endothelial fenestration structural changes in disease conditions is limited, partly due to the absence of robust methodologies to quantitate these structures. Herein, we propose a novel method for estimating the percentage of endothelial fenestration.
METHODS: An unbiased stereological method based on contiguity of two phases and surface area density estimation using isotropic uniform random line probes was developed. A line grid for intercept counting and classifying endothelial coverage of fenestrated versus non-fenestrated areas was designed. The method was applied to renal biopsies from 15 patients with Fabry disease and 9 normal living kidney donor controls.
RESULTS: The percentage of glomerular capillary endothelial coverage which was fenestrated was lower in Fabry patients (43 ± 12%) versus controls (53 ± 9%; p = 0.047). The fraction of endothelial surface which was fenestrated was greater on the peripheral versus mesangial zones of the capillary walls in both Fabry patients (p = 0.00002) and controls (p = 0.0005).
CONCLUSION: The proposed method provides an unbiased tool to quantitate endothelial fenestration changes in glomeruli. The practical example introduced showed reduced glomerular endothelial fenestration in Fabry nephropathy.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21659733      PMCID: PMC3121551          DOI: 10.1159/000327075

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  19 in total

1.  Estimation of surface area and length with the orientator.

Authors:  T Mattfeldt; G Mall; H Gharehbaghi; P Möller
Journal:  J Microsc       Date:  1990-09       Impact factor: 1.758

2.  Stratified laminae fenestratae (alveolus fenestratus endothelialis) in the glomerular capillaries of the mouse kidney.

Authors:  H Kondo; T Ushiki
Journal:  Arch Histol Jpn       Date:  1985-02

3.  Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.

Authors:  H J Baelde; M Eikmans; D W P Lappin; P P Doran; D Hohenadel; P-T Brinkkoetter; F J van der Woude; R Waldherr; T J Rabelink; E de Heer; J A Bruijn
Journal:  Kidney Int       Date:  2007-01-31       Impact factor: 10.612

4.  Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria.

Authors:  Hikaru Sugimoto; Yuki Hamano; David Charytan; Dominic Cosgrove; Mark Kieran; Akulapalli Sudhakar; Raghu Kalluri
Journal:  J Biol Chem       Date:  2003-01-21       Impact factor: 5.157

5.  Effect of gentamicin on glomerular ultrastructure.

Authors:  P S Avasthi; A P Evan; J W Huser; F C Luft
Journal:  J Lab Clin Med       Date:  1981-09

6.  Nature of glomerular dysfunction in pre-eclampsia.

Authors:  R A Lafayette; M Druzin; R Sibley; G Derby; T Malik; P Huie; C Polhemus; W M Deen; B D Myers
Journal:  Kidney Int       Date:  1998-10       Impact factor: 10.612

7.  Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium.

Authors:  Rebecca R Foster; Sadie C Slater; Jaqualine Seckley; Dontscho Kerjaschki; David O Bates; Peter W Mathieson; Simon C Satchell
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

8.  An electron microscope study of the glomerulus in nephrosis, glomerulonephritis, and lupus erythematosus.

Authors:  M G FARQUHAR; R L VERNIER; R A GOOD
Journal:  J Exp Med       Date:  1957-11-01       Impact factor: 14.307

Review 9.  Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier.

Authors:  Simon C Satchell; Filip Braet
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-07

10.  VEGF-C promotes survival in podocytes.

Authors:  R R Foster; S C Satchell; J Seckley; M S Emmett; K Joory; C Y Xing; M A Saleem; P W Mathieson; D O Bates; S J Harper
Journal:  Am J Physiol Renal Physiol       Date:  2006-03-08
View more
  6 in total

1.  Changes in Albuminuria But Not GFR are Associated with Early Changes in Kidney Structure in Type 2 Diabetes.

Authors:  Helen C Looker; Michael Mauer; Pierre-Jean Saulnier; Jennifer L Harder; Viji Nair; Carine M Boustany-Kari; Paolo Guarnieri; Jon Hill; Cordell A Esplin; Matthias Kretzler; Robert G Nelson; Behzad Najafian
Journal:  J Am Soc Nephrol       Date:  2019-06       Impact factor: 10.121

2.  Clinical parameters, LysoGb3, podocyturia, and kidney biopsy in children with Fabry disease: is a correlation possible?

Authors:  Juan Politei; Valeria Alberton; Oscar Amoreo; Norberto Antongiovanni; Maria Nieves Arán; Marcelo Barán; Gustavo Cabrera; Silvia Di Pietrantonio; Consuelo Durand; Alejandro Fainboim; Joaquin Frabasil; Fernando Gomez Pizarro; Roberto Iotti; Miguel Liern; Fernando Perretta; Diego Ripeau; Fernanda Toniolo; Hernan Trimarchi; Dana Velasques Rivas; Eric Wallace; Andrea Beatriz Schenone
Journal:  Pediatr Nephrol       Date:  2018-07-09       Impact factor: 3.714

3.  Effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys.

Authors:  Alexander Tschulakow; Sarah Christner; Sylvie Julien; Maximilian Ludinsky; Markus van der Giet; Ulrich Schraermeyer
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

4.  Mosaicism of podocyte involvement is related to podocyte injury in females with Fabry disease.

Authors:  Michael Mauer; Emily Glynn; Einar Svarstad; Camilla Tøndel; Marie-Claire Gubler; Michael West; Alexey Sokolovskiy; Chester Whitley; Behzad Najafian
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

5.  Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study.

Authors:  L J Smyth; J Kilner; V Nair; H Liu; E Brennan; K Kerr; N Sandholm; J Cole; E Dahlström; A Syreeni; R M Salem; R G Nelson; H C Looker; C Wooster; K Anderson; G J McKay; F Kee; I Young; D Andrews; C Forsblom; J N Hirschhorn; C Godson; P H Groop; A P Maxwell; K Susztak; M Kretzler; J C Florez; A J McKnight
Journal:  Clin Epigenetics       Date:  2021-05-01       Impact factor: 6.551

6.  Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial.

Authors:  Frits A Wijburg; Bernard Bénichou; Daniel G Bichet; Lorne A Clarke; Gabriela Dostalova; Alejandro Fainboim; Andreas Fellgiebel; Cassiano Forcelini; Kristina An Haack; Robert J Hopkin; Michael Mauer; Behzad Najafian; C Ronald Scott; Suma P Shankar; Beth L Thurberg; Camilla Tøndel; Anna Tylki-Szymańska; Uma Ramaswami
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.